Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05201014 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT05201014 · ClinicalTrials.gov record · last posted 2026-08-10

Cancer Survivor Cardiomyopathy Detection

Study acronym: CASCADE
StatusTerminated
PhaseNot specified
Started2022-03-03
View on ClinicalTrials.gov ↗
Why the trial stopped
diminished funding
from the ClinicalTrials.gov record
The purpose of this study is to improve the cardiovascular care of adult cancer survivors. The goal is to obtain the data necessary to plan and develop a nation-wide network of a screening program that can help provide cost-effective and long-term monitoring.

Protocol amendment history 4 changes detected by DataLookout

2026-08-11
Trial terminated
2026-08-11
Trial terminated: diminished funding
2026-08-11
Primary completion moved earlier: 2026-09-20 → 2026-02-09
2026-08-11
Completion moved earlier: 2026-09-20 → 2026-02-09
Trial Details
NCT Number NCT05201014
Lead Sponsor Mayo Clinic
Collaborators: Florida Heart Research Institute
Conditions Cardiovascular Diseases, Cancer
Enrollment 112 participants
Start Date 2022-03-03
Primary Completion 2026-02-09 (estimated)
Study Completion 2026-02-09 (estimated)
Updated on ClinicalTrials.gov 2026-08-10